Status: current, Defined. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4242581000168116 | Ultomiris (ravulizumab 300 mg / 30 mL) injection, 30 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4242591000168118 | Ultomiris 300 mg/30 mL injection, 30 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ultomiris 300 mg/30 mL injection, 30 mL vial | Is a | Ultomiris | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/30 mL injection, 30 mL vial | Is a | ravulizumab 300 mg/30 mL injection, vial | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/30 mL injection, 30 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/30 mL injection, 30 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/30 mL injection, 30 mL vial | has Australian BoSS | ravulizumab | true | Inferred relationship | Some | 950617338 | |
| Ultomiris 300 mg/30 mL injection, 30 mL vial | has intended active ingredient | ravulizumab | true | Inferred relationship | Some | 950617338 | |
| Ultomiris 300 mg/30 mL injection, 30 mL vial | has unit of use | vial | true | Inferred relationship | Some | 249276746 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ultomiris 300 mg/30 mL injection, 30 mL vial | has TPUU | True | Ultomiris 300 mg/30 mL injection, 30 mL vial | Inferred relationship | Some | 1738157655 |
| Ultomiris 300 mg/30 mL injection, 30 mL vial | has TPUU | True | Ultomiris 300 mg/30 mL injection, 30 mL vial | Inferred relationship | Some | 1260243052 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR